Genix Pharmaceuticals Corporation

GENPF · OTC
Analyze with AI
7/31/2025
4/30/2025
1/31/2025
10/31/2024
Operating Activities
Net Income-$84-$52-$107$154
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$15$8-$4$32
Other Non-Cash$57$30$48-$226
Operating Cash Flow-$11-$14-$63-$40
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$12$15$55$42
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$12$15$55$42
Forex Effect-$0$0$0$0
Net Chg. in Cash$0$1-$8$1
Supplemental Information
Beg. Cash$3$3$11$10
End Cash$3$4$3$11
Free Cash Flow-$11-$14-$63-$40